Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2U10EY011751 | U.S. NIH Grant/Contract | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Pediatric Eye Disease Investigator Group | NETWORK |
| National Eye Institute (NEI) | NIH |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of the study is to compare the effectiveness of 1 hour/day of binocular game play 7 days per week with 2 hours/day patching 7 days per week in children 5 to <17
The purpose of the study is to 1) compare the effectiveness of 1 hour/day of binocular game play 7 days per week (minimum of 4 days per week) with 2 hours/day patching 7 days per week, in children 5 to <13 years of age (younger cohort), as a non-inferiority study; and 2) to compare the effectiveness of 1 hour/day of binocular game play 7 days per week (minimum of 4 days per week) with 2 hours/day patching 7 days per week, in children 13 to <17 years of age (older cohort), as a superiority study.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Binocular Treatment | Experimental | Binocular computer game play 1 hour per day, 7 days per week (minimum of 4 days per week) |
|
| Patching Treatment | Active Comparator | Patching 2 hours per day, 7 days per week |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| iPad® | Device | Binocular therapy on iPad® |
| |
| Patching 2 hours per day, 7 days per week |
| Measure | Description | Time Frame |
|---|---|---|
| Change in Distance Visual Acuity From Baseline in the Younger Cohort (5 to <13 Years) | Monocular distance visual acuity (VA) in current refractive correction (if required) in each eye by a certified examiner using the electronic Amblyopia Treatment Study single-surround HOTV (ATS-HOTV) visual acuity protocol for children <7 years and the Electronic Early Treatment Diabetic Retinoscopy Study (E-ETDRS) visual acuity protocol for children ≥ 7 years on a study-certified acuity tester displaying single surrounded optotypes. For the younger cohort, the level of visual acuity is analyzed in the log of the Minimum Angle of Resolution (logMAR) scale (approximate range: -0.2 to 1.7) such that higher scores indicate poorer VA. Change in VA is computed as logMAR lines (positive values indicate improvement), defined as the difference between the enrollment and 16-week acuities (logMAR) multiplied by 10. | Baseline and 16 weeks |
| Mean Amblyopic Eye Visual Acuity (Younger Cohort) | Monocular distance visual acuity (VA) in current refractive correction (if required) in each eye by a certified examiner using the electronic Amblyopia Treatment Study single-surround HOTV (ATS-HOTV) visual acuity protocol for children <7 years and the Electronic Early Treatment Diabetic Retinoscopy Study (E-ETDRS) visual acuity protocol for children ≥ 7 years on a study-certified acuity tester displaying single surrounded optotypes. For the younger cohort, the level of visual acuity is analyzed in the log of the Minimum Angle of Resolution (logMAR) scale (approximate range: -0.2 to 1.7) such that higher scores indicate poorer VA. | 16 Weeks from baseline |
| Mean Change in Amblyopic-eye Visual Acuity in the Older Cohort (13 to <17 Years) | Monocular distance visual acuity (VA) in current refractive correction (if required) in each eye by a certified examiner using the Electronic Early Treatment Diabetic Retinoscopy Study (E-ETDRS) visual acuity protocol for children ≥ 7 years on a study-certified acuity tester displaying single surrounded optotypes. For the analyses in the older cohort, the level of VA is measured as letter scores (approximate range: 0 to 97 letters, lower scores indicate poorer VA) and change in VA from baseline is measured in letters (positive values indicate improvement), defined as the difference in letter scores between enrollment and follow-up. |
| Measure | Description | Time Frame |
|---|---|---|
| Number of Participants With Amblyopic-eye VA Improvement of 2 or More logMAR Lines (10 or More Letters if E-ETDRS) From Baseline | Monocular distance visual acuity (VA) in current refractive correction (if required) in each eye by a certified examiner using the electronic Amblyopia Treatment Study single-surround HOTV (ATS-HOTV) visual acuity protocol for children <7 years and the Electronic Early Treatment Diabetic Retinoscopy Study (E-ETDRS) visual acuity protocol for children ≥ 7 years on a study-certified acuity tester displaying single surrounded optotypes. Younger cohort: The level of VA is analyzed in the log of the Minimum Angle of Resolution (logMAR) scale (previously defined) and change in VA from baseline as logMAR lines (previously defined). Older cohort: The level of VA is measured as letter scores (previously defined) and VA change from baseline is measured in letters (previously defined). |
| Measure | Description | Time Frame |
|---|---|---|
| Percentage of Participants Reporting >75% of Prescribed Treatment Completed (Subjective Measures of Adherence) | Participants who were randomly assigned to binocular treatment were prescribed 1 hour of game play per day, 7 days a week while those assigned to the patching group were prescribed 2 hours of daily patching, 7 days per week. Parents were asked to record the amount of time that the participant played the binocular game (binocular treatment group) or wore the patch (patching group) each day on a calendar. At each study visit, the investigator estimated the frequency and duration of treatment that the participant completed based on the parent-reported calendars and discussion with the participant and/or parent(s). For analysis, the percentage of prescribed treatment completed was calculated as the total number of reported hours of treatment completed since baseline divided by the total number of prescribed hours (refer to the intended treatment dose/frequency listed above) since baseline. |
Inclusion Criteria:
Age 5 to <17 years
Amblyopia associated with strabismus, anisometropia, or both (previously treated or untreated)
Criteria for strabismus: At least one of the following must be met:
Criteria for anisometropia: At least one of the following criteria must be met:
Criteria for combined-mechanism amblyopia: Both of the following criteria must be met:
No amblyopia treatment in the past 2 weeks (patching, atropine, Bangerter, vision therapy)
Refractive correction (spectacles or contact lenses, if applicable) must meet the following criteria at enrollment and be based on a cycloplegic refraction that is not more than 7 months old.
Requirements for Correction of Refractive Error:
For subjects meeting criteria for strabismic (only) amblyopia (see 2.2.1 #2 above):
• Hypermetropia, if corrected, must not be under-corrected by more than +1.50 D spherical equivalent, and the reduction in plus sphere must be symmetric in the two eyes.
For subjects meeting criteria for anisometropic or combined-mechanism amblyopia (see 2.2.1 #2 above):
Refractive corrections meeting the above criteria must be worn for either:
Monocular or binocular contact lens wear is allowed provided the contact lenses meet the above refractive requirements at the corneal plane. The same form of correction must be worn throughout the entire study during study procedures (i.e., no changing between contacts and spectacles while patching or while game-playing or study testing). Safety glasses are not required for subjects wearing contact lenses, but investigators are encouraged to suggest safety glasses be worn over contact lenses.
Visual acuity, measured in each eye without cycloplegia in current refractive correction (if applicable) within 7 days prior to randomization using the Amblyopia Treatment Study single-surround HOTV (ATS-HOTV) visual acuity protocol for children < 7 years and the Electronic Early Treatment Diabetic Retinopathy Study (E-ETDRS) visual acuity protocol for children ≥ 7 years on a study-approved device displaying single surrounded optotypes, as follows:
Heterotropia or heterophoria with a total near deviation of ≤ 10∆ (measured by PACT).
Ability to align the nonius cross on the binocular game system (angles of ocular deviation >10∆ would require the nonius cross to be adjusted to such an extent that playing of the game would be compromised).
Subject is able to play Hess Falling Blocks game on the study iPad® (on easy setting) under binocular conditions (with red-green glasses), as demonstrated by scoring at least 1 line in the office.
Investigator is willing to prescribe computer game play or patching per protocol.
Parent understands the protocol and is willing to accept randomization.
Parent has phone (or access to phone) and is willing to be contacted by Jaeb Center staff.
Relocation outside of area of an active Pediatric Eye Disease Investigator Group (PEDIG) site for this study within the next 16 weeks is not anticipated.
Exclusion Criteria:
A subject is excluded for any of the following reasons:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Jonathan Holmes, MD | Mayo Clinic | Study Chair |
| Vivan Manh, OD | University of Washington | Study Chair |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Mayo Clinic | Rochester | Minnesota | 55905 | United States | ||
| Seattle Children's Hospital, University of Washington |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 27812703 | Result | Holmes JM, Manh VM, Lazar EL, Beck RW, Birch EE, Kraker RT, Crouch ER, Erzurum SA, Khuddus N, Summers AI, Wallace DK; Pediatric Eye Disease Investigator Group. Effect of a Binocular iPad Game vs Part-time Patching in Children Aged 5 to 12 Years With Amblyopia: A Randomized Clinical Trial. JAMA Ophthalmol. 2016 Dec 1;134(12):1391-1400. doi: 10.1001/jamaophthalmol.2016.4262. | |
| 35129211 | Derived | Tailor V, Ludden S, Bossi M, Bunce C, Greenwood JA, Dahlmann-Noor A. Binocular versus standard occlusion or blurring treatment for unilateral amblyopia in children aged three to eight years. Cochrane Database Syst Rev. 2022 Feb 7;2(2):CD011347. doi: 10.1002/14651858.CD011347.pub3. |
| Label | URL |
|---|---|
| PEDIG Public Website | View source |
Not provided
In accordance with the NIH data sharing policy, a de-identified database is placed in the public domain on the PEDIG public website after the completion of each protocol and publication of the primary manuscript.
After primary manuscripts are published
Users accessing the data must enter an email address.
Not provided
Not provided
Two separate sub-studies based on age at enrollment
Younger Cohort defined as 5 to <13 years of age Older Cohort defined as 13 to <17 years of age
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | Binocular Treatment Younger | Binocular computer game play 1 hour per day, 7 days per week (minimum of 4 days per week) iPad®: Binocular therapy on iPad® |
| FG001 | Patching Treatment Younger | Patching 2 hours per day, 7 days per week |
| FG002 | Binocular Treatment Older | Binocular computer game play 1 hour per day, 7 days per week (minimum of 4 days per week) iPad®: Binocular therapy on iPad® |
| FG003 | Patching Treatment Older | Patching 2 hours per day, 7 days per week |
| Title | Milestones | Reasons Not Completed | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall Study |
|
|
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | Binocular Treatment Younger Cohort (5 to <13 Years) | Binocular computer game play 1 hour per day, 7 days per week (minimum of 4 days per week) iPad®: Binocular therapy on iPad® |
| BG001 | Patching Treatment Younger Cohort (5 to <13 Years) |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Categorical | Count of Participants |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Change in Distance Visual Acuity From Baseline in the Younger Cohort (5 to <13 Years) | Monocular distance visual acuity (VA) in current refractive correction (if required) in each eye by a certified examiner using the electronic Amblyopia Treatment Study single-surround HOTV (ATS-HOTV) visual acuity protocol for children <7 years and the Electronic Early Treatment Diabetic Retinoscopy Study (E-ETDRS) visual acuity protocol for children ≥ 7 years on a study-certified acuity tester displaying single surrounded optotypes. For the younger cohort, the level of visual acuity is analyzed in the log of the Minimum Angle of Resolution (logMAR) scale (approximate range: -0.2 to 1.7) such that higher scores indicate poorer VA. Change in VA is computed as logMAR lines (positive values indicate improvement), defined as the difference between the enrollment and 16-week acuities (logMAR) multiplied by 10. | Visual acuity analyses included only data from participants who completed the 16-week visit within the predefined analysis window (14 to <20 weeks after randomization), analysis is adjusted for baseline covariates of age and visual acuity. | Posted | Mean | 95% Confidence Interval | LogMAR lines | Baseline and 16 weeks |
Not provided
Not provided
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Binocular Treatment Younger | Binocular computer game play 1 hour per day, 7 days per week (minimum of 4 days per week) iPad®: Binocular therapy on iPad® |
Not provided
Not provided
Not provided
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Raymond Kraker, M.S.P.H., Director of PEDIG Coordinating Center | Jaeb Center for Health Research | 813-975-8690 | rkraker@jaeb.org |
Not provided
| ID | Term |
|---|---|
| D000550 | Amblyopia |
| ID | Term |
|---|---|
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
| D009422 | Nervous System Diseases |
| D014786 | Vision Disorders |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Other |
|
|
| Baseline and 16 weeks |
| Mean Amblyopic-eye Visual Acuity in the Older Cohort (13 to <17 Years) | Monocular distance visual acuity (VA) in current refractive correction (if required) in each eye by a certified examiner using the Electronic Early Treatment Diabetic Retinoscopy Study (E-ETDRS) visual acuity protocol for children ≥ 7 years on a study-certified acuity tester displaying single surrounded optotypes. For the analyses in the older cohort, the level of VA is measured as letter scores (approximate range: 0 to 97 letters, lower scores indicate poorer VA) and change in VA from baseline is measured in letters (positive values indicate improvement), defined as the difference in letter scores between enrollment and follow-up. | 16 weeks |
| Distribution of Change in Amblyopic-eye Visual Acuity | Monocular distance visual acuity (VA) in current refractive correction (if required) in each eye by a certified examiner using the electronic Amblyopia Treatment Study single-surround HOTV (ATS-HOTV) visual acuity protocol for children <7 years and the Electronic Early Treatment Diabetic Retinoscopy Study (E-ETDRS) visual acuity protocol for children ≥ 7 years on a study-certified acuity tester displaying single surrounded optotypes. Younger cohort: The level of VA is analyzed in the log of the Minimum Angle of Resolution (logMAR) scale (previously defined) and change in VA from baseline as logMAR lines (previously defined). Older cohort: The level of VA is measured as letter scores (previously defined) and VA change from baseline is measured in letters (previously defined). | Baseline and 16 weeks |
| Distribution of Amblyopic-eye Visual Acuity | Monocular distance visual acuity (VA) in current refractive correction (if required) in each eye by a certified examiner using the electronic Amblyopia Treatment Study single-surround HOTV (ATS-HOTV) visual acuity protocol for children <7 years and the Electronic Early Treatment Diabetic Retinoscopy Study (E-ETDRS) visual acuity protocol for children ≥ 7 years on a study-certified acuity tester displaying single surrounded optotypes. Younger cohort: The level of VA is analyzed in the log of the Minimum Angle of Resolution (logMAR) scale (previously defined) and change in VA from baseline as logMAR lines (previously defined). Older cohort: The level of VA is measured as letter scores (previously defined) and VA change from baseline is measured in letters (previously defined). | At 16 weeks |
| Baseline and 16-week visit |
| Number of Participants With Resolution of Amblyopia | Monocular distance visual acuity (VA) in current refractive correction (if required) in each eye by a certified examiner using the electronic Amblyopia Treatment Study single-surround HOTV (ATS-HOTV) visual acuity protocol for children <7 years and the Electronic Early Treatment Diabetic Retinoscopy Study (E-ETDRS) visual acuity protocol for children ≥ 7 years on a study-certified acuity tester displaying single surrounded optotypes. The level of VA is analyzed in the log of the Minimum Angle of Resolution (logMAR) scale (previously defined) for the younger cohort and as letter scores (previously defined) for the older cohort. Resolution of amblyopia was defined as having an amblyopic-eye VA of 20/25 or better (≥ 78 letters if E-ETDRS) and within 1 logMAR line (5 letters if E-ETDRS) of the fellow eye VA. | 16-week visit |
| Time Course of Visual Acuity Improvement | Monocular distance visual acuity (VA) in current refractive correction (if required) in each eye by a certified examiner using the electronic Amblyopia Treatment Study single-surround HOTV (ATS-HOTV) visual acuity protocol for children <7 years and the Electronic Early Treatment Diabetic Retinoscopy Study (E-ETDRS) visual acuity protocol for children ≥ 7 years on a study-certified acuity tester displaying single surrounded optotypes. For the younger cohort, the level of VA is analyzed in the log of the Minimum Angle of Resolution (logMAR) scale (approximate range: -0.2 to 1.7, higher values indicate poorer VA) and change in VA from baseline as logMAR lines (positive values indicate improvement), defined as the difference between the enrollment and follow-up acuities (logMAR) multiplied by 10. | Baseline, 4 weeks, 8 weeks, 12 weeks and 16 weeks |
| Younger Cohort: Change in Distance Visual Acuity From Baseline According to Subgroups | Monocular distance visual acuity (VA) in current refractive correction (if required) in each eye by a certified examiner using the electronic Amblyopia Treatment Study single-surround HOTV (ATS-HOTV) visual acuity protocol for children <7 years and the Electronic Early Treatment Diabetic Retinoscopy Study (E-ETDRS) visual acuity protocol for children ≥ 7 years on a study-certified acuity tester displaying single surrounded optotypes. For the younger cohort, the level of VA is analyzed in the log of the Minimum Angle of Resolution (logMAR) scale (previously defined) and change in VA from baseline as logMAR lines (previously defined, positive values indicate improvement), For both descriptive and formal subgroup analyses, all subgroup factors were pre-specified except for baseline stereoacuity (nil, better than nil). We performed post hoc descriptive analyses to explore treatment effect by baseline age (5 to <7 yrs, 7 to <13 yrs) and prior amblyopia treatment (yes/no). | Baseline and 16 weeks |
| Older Cohort: Change in Distance Visual Acuity From Baseline According to Subgroups | Monocular distance visual acuity (VA) in current refractive correction (if required) in each eye by a certified examiner using the Electronic Early Treatment Diabetic Retinoscopy Study (E-ETDRS) visual acuity protocol for children ≥ 7 years on a study-certified acuity tester displaying single surrounded optotypes. For the analyses in the older cohort, the level of VA is measured as letter scores (previously defined) and change in VA from baseline is measured in letters (positive values indicate improvement), defined as the difference in letter scores between enrollment and follow-up. Subgroup factors of interest were pre-specified except for baseline stereoacuity (nil, better than nil). | Baseline and 16 weeks |
| Distribution of Stereoacuity Scores | Stereoacuity was tested at near in current refractive correction. Stereoacuity scores (measure as seconds of arc) were calculated based on the Randot Butterfly (scores: 2000, Nil) and Randot Preschool stereoacuity (scores: 800, 400, 200, 100, 60 and 40) test methods. Lower scores indicate better stereoacuity. Results of the Randot Butterfly test were analyzed as 2000 seconds of arc (if correct response). Nil was assigned a score of 4000 seconds of arc and was defined as (1) an incorrect response on the butterfly in absence of a correct response on the 800 seconds of arc level of the Randot Preschool stereoacuity test or (2) an incorrect response on the 800 seconds of arc level if the butterfly was not attempted. | 16 weeks |
| Median Stereoacuity Score (Seconds of Arc) | Stereoacuity was tested at near in current refractive correction. Stereoacuity scores (measure as seconds of arc) were calculated based on the Randot Butterfly (scores: 2000, Nil) and Randot Preschool stereoacuity (scores: 800, 400, 200, 100, 60 and 40) test methods. Lower scores indicate better stereoacuity. Results of the Randot Butterfly test were analyzed as 2000 seconds of arc (if correct response). Nil was assigned a score of 4000 seconds of arc and was defined as (1) an incorrect response on the butterfly in absence of a correct response on the 800 seconds of arc level of the Randot Preschool stereoacuity test or (2) an incorrect response on the 800 seconds of arc level if the butterfly was not attempted. A logarithm base 10 transformation was used to convert stereoacuity scores (seconds of arc) to the log scale (conversion reference listed below), which was used to calculate descriptive statistics. Results of the descriptive analyses are reported as seconds of arc. | 16 weeks |
| Distribution of Stereoacuity Scores (Participants With no History of Strabismus) | Stereoacuity was tested at near in current refractive correction. Stereoacuity scores (measure as seconds of arc) were calculated based on the Randot Butterfly (scores: 2000, Nil) and Randot Preschool stereoacuity (scores: 800, 400, 200, 100, 60 and 40) test methods. Lower scores indicate better stereoacuity. Results of the Randot Butterfly test were analyzed as 2000 seconds of arc (if correct response). Nil was assigned a score of 4000 seconds of arc and was defined as (1) an incorrect response on the butterfly in absence of a correct response on the 800 seconds of arc level of the Randot Preschool stereoacuity test or (2) an incorrect response on the 800 seconds of arc level if the butterfly was not attempted. | 16 weeks |
| Distribution of Change in Stereoacuity Scores From Baseline | Stereoacuity was tested at near in current refractive correction. Stereoacuity scores (seconds of arc) were calculated based on the Randot Butterfly (scores: 2000, Nil) and Randot Preschool stereoacuity (scores: 800, 400, 200, 100, 60 and 40) test methods. Lower scores indicate better stereoacuity. Results of the Randot Butterfly test were analyzed as 2000 (if correct response). Nil (4000 ) was defined as (1) an incorrect response on the butterfly in absence of a correct response on the 800 seconds of arc level of the Randot Preschool stereoacuity test or (2) an incorrect response on the 800 seconds of arc level if the butterfly was not attempted. For each visit, stereoacuity scores were ordered and assigned a rank score. Change in stereoacuity was calculated as the difference in ranked score between the enrollment and 16-week stereoacuity scores. | Baseline and 16 weeks |
| Distribution of Change in Stereoacuity Scores From Baseline (Participants With no History of Strabismus) | Stereoacuity was tested at near in current refractive correction. Stereoacuity scores (seconds of arc) were calculated based on the Randot Butterfly (scores: 2000, Nil) and Randot Preschool stereoacuity (scores: 800, 400, 200, 100, 60 and 40) test methods. Lower scores indicate better stereoacuity. Results of the Randot Butterfly test were analyzed as 2000 (if correct response). Nil (4000 ) was defined as (1) an incorrect response on the butterfly in absence of a correct response on the 800 seconds of arc level of the Randot Preschool stereoacuity test or (2) an incorrect response on the 800 seconds of arc level if the butterfly was not attempted. For each visit, stereoacuity scores were ordered and assigned a rank score. Change in stereoacuity was calculated as the difference in ranked score between the enrollment and 16-week stereoacuity scores. | Baseline and 16 weeks |
| Binocular Treatment Group: Adherence and Fellow-eye Contrast (iPad Log File Data) | Participants assigned to binocular treatment were prescribed the binocular falling blocks game for 1 hour per day (allowing division into shorter sessions), 7 days per week for 16 weeks, with instructions to perform therapy a minimum of 4 days per week if unable to play for 7 days per week. The iPad device automatically recorded duration of game play, fellow-eye contrast, and performance. Adherence was calculated as the total hours of game play since baseline divided by the total prescribed hours (based on intended dose of 1 hour a day, 7 days per week) since baseline. The fellow-eye contrast was initially set to 20% (amblyopic eye always at 100%) and automatically increased or decreased by 10% increments (lowest level of 10%) or left unchanged from the last contrast level, based on the previous day's game play duration (at least 30 minutes required for contrast change) and performance (increased if scored 1000 points or more). Post hoc analysis: 4-week fellow-eye contrast. | Entire study period, up to 16 weeks |
| Binocular Treatment Group: Median Adherence With Prescribed Game Play (iPad Log File Data) | Participants assigned to binocular treatment were prescribed the binocular falling blocks game for 1 hour per day (allowing division into shorter sessions), 7 days per week for 16 weeks, with instructions to perform therapy a minimum of 4 days per week if unable to play for 7 days per week. The iPad device automatically recorded duration of game play, fellow-eye contrast, and performance. Adherence was calculated as the % of prescribed treatment actually completed: total hours of game play since baseline divided by the total prescribed hours (based on intended dose of 1 hour a day, 7 days per week) since baseline. | Entire study period, up to 16 weeks |
| 16 Weeks from baseline |
| Participants Who Received Non-protocol, Alternative Treatment During the Study | Participants who were randomly assigned to binocular treatment were prescribed 1 hour of game play per day, 7 days a week while those assigned to the patching group were prescribed 2 hours of daily patching, 7 days per week. The number of participants who received non-protocol, alternative treatment was tabulated by treatment group. | Entire study period, up to 16 weeks |
| Safety Analysis: Distribution of the Change in Fellow-eye Visual Acuity From Baseline | Monocular distance visual acuity (VA) in current refractive correction (if required) in each eye by a certified examiner using the electronic ATS-HOTV visual acuity protocol for children <7 years and the E-ETDRS visual acuity protocol for children ≥ 7 years on a study-certified acuity tester displaying single surrounded optotypes. The change in visual acuity is analyzed as logMAR lines for the younger cohort and as letters for the older cohort. | 16-week visit |
| Safety Analysis: Change in Fellow-eye Visual Acuity From Baseline (Younger Cohort) | Monocular distance visual acuity (VA) in current refractive correction (if required) in each eye by a certified examiner using the electronic Amblyopia Treatment Study single-surround HOTV (ATS-HOTV) visual acuity protocol for children <7 years and the Electronic Early Treatment Diabetic Retinoscopy Study (E-ETDRS) visual acuity protocol for children ≥ 7 years on a study-certified acuity tester displaying single surrounded optotypes. For the younger cohort, the level of visual acuity is analyzed in the log of the Minimum Angle of Resolution (logMAR) scale (approximate range: -0.2 to 1.7) such that higher scores indicate poorer VA. Change in VA is computed as logMAR lines (positive values indicate improvement), defined as the difference between the enrollment and 16-week acuities (logMAR) multiplied by 10. For this safety analysis, the change in fellow-eye visual acuity (logMAR lines) was computed by treatment group, adjusting for baseline visual acuity. | 16-week visit |
| Safety Analysis: Change in Fellow-eye Visual Acuity From Baseline (Older Cohort) | Monocular distance visual acuity (VA) in current refractive correction (if required) in each eye by a certified examiner using the Electronic Early Treatment Diabetic Retinoscopy Study (E-ETDRS) visual acuity protocol for children ≥ 7 years on a study-certified acuity tester displaying single surrounded optotypes. For the analyses in the older cohort, the level of VA is measured as letter scores (approximate range: 0 to 97 letters, lower scores indicate poorer VA) and change in VA from baseline is measured in letters (positive values indicate improvement), defined as the difference in letter scores between enrollment and follow-up. The change in fellow-eye visual acuity (letters) from baseline (positive values indicate improvement) was computed by treatment group, adjusting for baseline visual acuity. | 16-week visit |
| Safety Analysis: Development of a New Tropia and/or Worsening of a Pre-existing Deviation by 10 pd | Ocular alignment will be assessed in current refractive correction by the cover/uncover test, simultaneous prism and cover test (SPCT), and prism and alternate cover test (PACT) in primary gaze at distance (3 meters) and at near (1/3 meter). Participants were classified according to whether they met the any of the following criteria at the 16-week visit: development of a new tropia (measured by SPCT) and/or worsening of a pre-existing deviation by 10 prism diopters (pd) measured by SPCT. | 16 weeks |
| Safety Analysis: Distribution of Diplopia Frequency at 16 Weeks (Parent-reported) | A standardized questionnaire was administered to participants and their parents to assess the presence and frequency of any diplopia since the last study visit. | 16 weeks |
| Safety Analysis: Distribution of Diplopia Frequency at 16 Weeks (Participant-reported) | A standardized questionnaire was administered to participants and their parents to assess the presence and frequency of any diplopia since the last study visit. | 16 weeks |
| Safety Analysis: Distribution of Maximum Frequency of Diplopia Reported Across Follow-up (Parent-reported) | A standardized questionnaire was administered to participants and their parents to assess the presence and frequency of any diplopia since the last study visit. | Across study follow-up visits, up to 16 weeks |
| Safety Analysis: Distribution of Maximum Frequency of Diplopia Reported Across Study Follow-up (Participant-reported) | A standardized questionnaire was administered to participants and their parents to assess the presence and frequency of any diplopia since the last study visit. | Across study follow-up visits, up to 16 weeks |
| Seattle |
| Washington |
| 98105 |
| United States |
| Withdrawal by Subject |
|
Patching 2 hours per day, 7 days per week Patching 2 hours per day, 7 days per week |
| BG002 | Binocular Treatment Older Cohort (13 to <17 Years) | Binocular computer game play 1 hour per day, 7 days per week (minimum of 4 days per week) iPad®: Binocular therapy on iPad® |
| BG003 | Patching Treatment Older Cohort (13 to <17 Years) | Patching 2 hours per day, 7 days per week Patching 2 hours per day, 7 days per week |
| BG004 | Total | Total of all reporting groups |
| Participants |
|
| Age, Continuous | Mean | Standard Deviation | years |
|
| Age, Customized | Count of Participants | Participants | No |
|
| Sex: Female, Male | Count of Participants | Participants | No |
|
| Race/Ethnicity, Customized | Count of Participants | Participants | No |
|
| Distance Amblyopic-Eye Visual Acuity | Count of Participants | Participants |
|
| Baseline Stereoacuity (Seconds of Arc) | Stereoacuity scores (seconds of arc) were calculated based on the Randot Butterfly (scores: 2000, Nil) and Randot Preschool stereoacuity (scores: 800, 400, 200, 100, 60 and 40) test methods. Lower scores indicate better stereoacuity. Results of the Randot Butterfly test were analyzed as 2000 (if correct response). Nil (4000 ) was defined as (1) an incorrect response on the butterfly in absence of a correct response on the 800 seconds of arc level of the Randot Preschool stereoacuity test or (2) an incorrect response on the 800 seconds of arc level if the butterfly was not attempted. | Count of Participants | Participants |
|
| Baseline Stereoacuity (Seconds of Arc) | Stereoacuity was tested at near in current refractive correction. Stereoacuity scores (measured as seconds of arc) were calculated based on the Randot Butterfly (scores: 2000, Nil) and Randot Preschool (scores: 800, 400, 200, 100, 60 and 40) stereoacuity test methods as previously described. Lower scores indicate better stereoacuity. A logarithm base 10 transformation was used to convert stereoacuity scores (Nil was assigned a score of 4000) to the log scale to calculate descriptive statistics (reported as seconds of arc). | Descriptive statistics were computed for baseline stereoacuity by treatment group for all participants and a subset of participants with no history of strabismus. The younger (age 5 to <7 years) and older (age 7 to <13 years) were analyzed as separate study cohorts. Results of the descriptive analyses are reported as seconds of arc. | Median | Full Range | Seconds of Arc |
|
| Amblyopia Cause | Count of Participants | Participants |
|
| ID | Title | Description |
|---|
| OG000 | Binocular Treatment Younger | Binocular computer game play 1 hour per day, 7 days per week (minimum of 4 days per week) iPad®: Binocular therapy on iPad® |
| OG001 | Patching Treatment Younger | Patching 2 hours per day, 7 days per week Patching 2 hours per day, 7 days per week |
|
|
|
| Primary | Mean Amblyopic Eye Visual Acuity (Younger Cohort) | Monocular distance visual acuity (VA) in current refractive correction (if required) in each eye by a certified examiner using the electronic Amblyopia Treatment Study single-surround HOTV (ATS-HOTV) visual acuity protocol for children <7 years and the Electronic Early Treatment Diabetic Retinoscopy Study (E-ETDRS) visual acuity protocol for children ≥ 7 years on a study-certified acuity tester displaying single surrounded optotypes. For the younger cohort, the level of visual acuity is analyzed in the log of the Minimum Angle of Resolution (logMAR) scale (approximate range: -0.2 to 1.7) such that higher scores indicate poorer VA. | Visual acuity analyses included only data from participants who completed the 16-week visit within the predefined analysis window (14 to <20 weeks after randomization). | Posted | Mean | Standard Deviation | LogMAR | 16 Weeks from baseline |
|
|
|
| Primary | Mean Change in Amblyopic-eye Visual Acuity in the Older Cohort (13 to <17 Years) | Monocular distance visual acuity (VA) in current refractive correction (if required) in each eye by a certified examiner using the Electronic Early Treatment Diabetic Retinoscopy Study (E-ETDRS) visual acuity protocol for children ≥ 7 years on a study-certified acuity tester displaying single surrounded optotypes. For the analyses in the older cohort, the level of VA is measured as letter scores (approximate range: 0 to 97 letters, lower scores indicate poorer VA) and change in VA from baseline is measured in letters (positive values indicate improvement), defined as the difference in letter scores between enrollment and follow-up. | Mean change in amblyopic-eye visual acuity from baseline to 16 weeks from participants who completed 16-week visit within pre-specified analysis window (148 to 196 days after randomization) | Posted | Mean | 95% Confidence Interval | letters | Baseline and 16 weeks |
|
|
|
|
| Primary | Mean Amblyopic-eye Visual Acuity in the Older Cohort (13 to <17 Years) | Monocular distance visual acuity (VA) in current refractive correction (if required) in each eye by a certified examiner using the Electronic Early Treatment Diabetic Retinoscopy Study (E-ETDRS) visual acuity protocol for children ≥ 7 years on a study-certified acuity tester displaying single surrounded optotypes. For the analyses in the older cohort, the level of VA is measured as letter scores (approximate range: 0 to 97 letters, lower scores indicate poorer VA) and change in VA from baseline is measured in letters (positive values indicate improvement), defined as the difference in letter scores between enrollment and follow-up. | Participants that completed 16-week visit within pre-specified analysis window (148 to 196 days after randomization) | Posted | Mean | Standard Deviation | letters | 16 weeks |
|
|
|
| Primary | Distribution of Change in Amblyopic-eye Visual Acuity | Monocular distance visual acuity (VA) in current refractive correction (if required) in each eye by a certified examiner using the electronic Amblyopia Treatment Study single-surround HOTV (ATS-HOTV) visual acuity protocol for children <7 years and the Electronic Early Treatment Diabetic Retinoscopy Study (E-ETDRS) visual acuity protocol for children ≥ 7 years on a study-certified acuity tester displaying single surrounded optotypes. Younger cohort: The level of VA is analyzed in the log of the Minimum Angle of Resolution (logMAR) scale (previously defined) and change in VA from baseline as logMAR lines (previously defined). Older cohort: The level of VA is measured as letter scores (previously defined) and VA change from baseline is measured in letters (previously defined). | Posted | Count of Participants | Participants | Baseline and 16 weeks |
|
|
|
| Primary | Distribution of Amblyopic-eye Visual Acuity | Monocular distance visual acuity (VA) in current refractive correction (if required) in each eye by a certified examiner using the electronic Amblyopia Treatment Study single-surround HOTV (ATS-HOTV) visual acuity protocol for children <7 years and the Electronic Early Treatment Diabetic Retinoscopy Study (E-ETDRS) visual acuity protocol for children ≥ 7 years on a study-certified acuity tester displaying single surrounded optotypes. Younger cohort: The level of VA is analyzed in the log of the Minimum Angle of Resolution (logMAR) scale (previously defined) and change in VA from baseline as logMAR lines (previously defined). Older cohort: The level of VA is measured as letter scores (previously defined) and VA change from baseline is measured in letters (previously defined). | Participants that completed 16-week visit within pre-specified analysis window (148 to 196 days after randomization) | Posted | Count of Participants | Participants | At 16 weeks |
|
|
|
| Secondary | Number of Participants With Amblyopic-eye VA Improvement of 2 or More logMAR Lines (10 or More Letters if E-ETDRS) From Baseline | Monocular distance visual acuity (VA) in current refractive correction (if required) in each eye by a certified examiner using the electronic Amblyopia Treatment Study single-surround HOTV (ATS-HOTV) visual acuity protocol for children <7 years and the Electronic Early Treatment Diabetic Retinoscopy Study (E-ETDRS) visual acuity protocol for children ≥ 7 years on a study-certified acuity tester displaying single surrounded optotypes. Younger cohort: The level of VA is analyzed in the log of the Minimum Angle of Resolution (logMAR) scale (previously defined) and change in VA from baseline as logMAR lines (previously defined). Older cohort: The level of VA is measured as letter scores (previously defined) and VA change from baseline is measured in letters (previously defined). | Analysis was limited to participants who completed the 16-week visit within the pre-specified analysis window (14 to <20 weeks after randomization). | Posted | Count of Participants | Participants | Baseline and 16-week visit |
|
|
|
|
| Secondary | Number of Participants With Resolution of Amblyopia | Monocular distance visual acuity (VA) in current refractive correction (if required) in each eye by a certified examiner using the electronic Amblyopia Treatment Study single-surround HOTV (ATS-HOTV) visual acuity protocol for children <7 years and the Electronic Early Treatment Diabetic Retinoscopy Study (E-ETDRS) visual acuity protocol for children ≥ 7 years on a study-certified acuity tester displaying single surrounded optotypes. The level of VA is analyzed in the log of the Minimum Angle of Resolution (logMAR) scale (previously defined) for the younger cohort and as letter scores (previously defined) for the older cohort. Resolution of amblyopia was defined as having an amblyopic-eye VA of 20/25 or better (≥ 78 letters if E-ETDRS) and within 1 logMAR line (5 letters if E-ETDRS) of the fellow eye VA. | Analysis was limited to participants who completed the 16-week visit within the pre-specified analysis window (14 to <20 weeks after randomization). | Posted | Count of Participants | Participants | 16-week visit |
|
|
|
|
| Secondary | Time Course of Visual Acuity Improvement | Monocular distance visual acuity (VA) in current refractive correction (if required) in each eye by a certified examiner using the electronic Amblyopia Treatment Study single-surround HOTV (ATS-HOTV) visual acuity protocol for children <7 years and the Electronic Early Treatment Diabetic Retinoscopy Study (E-ETDRS) visual acuity protocol for children ≥ 7 years on a study-certified acuity tester displaying single surrounded optotypes. For the younger cohort, the level of VA is analyzed in the log of the Minimum Angle of Resolution (logMAR) scale (approximate range: -0.2 to 1.7, higher values indicate poorer VA) and change in VA from baseline as logMAR lines (positive values indicate improvement), defined as the difference between the enrollment and follow-up acuities (logMAR) multiplied by 10. | Analysis included participants with at least one follow-up visit (completed within the analysis window). There were 6 participants (4 in the binocular group, 2 in the patching group) who were excluded from the time course analysis because they did not have any follow-up exams. | Posted | Mean | Standard Deviation | logMAR lines | Baseline, 4 weeks, 8 weeks, 12 weeks and 16 weeks |
|
|
|
|
| Secondary | Younger Cohort: Change in Distance Visual Acuity From Baseline According to Subgroups | Monocular distance visual acuity (VA) in current refractive correction (if required) in each eye by a certified examiner using the electronic Amblyopia Treatment Study single-surround HOTV (ATS-HOTV) visual acuity protocol for children <7 years and the Electronic Early Treatment Diabetic Retinoscopy Study (E-ETDRS) visual acuity protocol for children ≥ 7 years on a study-certified acuity tester displaying single surrounded optotypes. For the younger cohort, the level of VA is analyzed in the log of the Minimum Angle of Resolution (logMAR) scale (previously defined) and change in VA from baseline as logMAR lines (previously defined, positive values indicate improvement), For both descriptive and formal subgroup analyses, all subgroup factors were pre-specified except for baseline stereoacuity (nil, better than nil). We performed post hoc descriptive analyses to explore treatment effect by baseline age (5 to <7 yrs, 7 to <13 yrs) and prior amblyopia treatment (yes/no). | Visual acuity analyses included only data from participants who completed the 16-week visit within the predefined analysis window (14 to <20 weeks after randomization). Formal subgroup analyses are adjusted for baseline covariates of visual acuity and age. | Posted | Mean | Standard Deviation | LogMAR lines | Baseline and 16 weeks |
|
|
|
|
| Secondary | Older Cohort: Change in Distance Visual Acuity From Baseline According to Subgroups | Monocular distance visual acuity (VA) in current refractive correction (if required) in each eye by a certified examiner using the Electronic Early Treatment Diabetic Retinoscopy Study (E-ETDRS) visual acuity protocol for children ≥ 7 years on a study-certified acuity tester displaying single surrounded optotypes. For the analyses in the older cohort, the level of VA is measured as letter scores (previously defined) and change in VA from baseline is measured in letters (positive values indicate improvement), defined as the difference in letter scores between enrollment and follow-up. Subgroup factors of interest were pre-specified except for baseline stereoacuity (nil, better than nil). | Visual acuity analyses included only data from participants who completed the 16-week visit within the predefined analysis window (14 to <20 weeks after randomization). | Posted | Mean | Standard Deviation | Letters | Baseline and 16 weeks |
|
|
|
| Secondary | Distribution of Stereoacuity Scores | Stereoacuity was tested at near in current refractive correction. Stereoacuity scores (measure as seconds of arc) were calculated based on the Randot Butterfly (scores: 2000, Nil) and Randot Preschool stereoacuity (scores: 800, 400, 200, 100, 60 and 40) test methods. Lower scores indicate better stereoacuity. Results of the Randot Butterfly test were analyzed as 2000 seconds of arc (if correct response). Nil was assigned a score of 4000 seconds of arc and was defined as (1) an incorrect response on the butterfly in absence of a correct response on the 800 seconds of arc level of the Randot Preschool stereoacuity test or (2) an incorrect response on the 800 seconds of arc level if the butterfly was not attempted. | The analysis included all participants who completed a 16-week exam regardless of whether or not the exam was completed within the pre-specified analysis window. | Posted | Count of Participants | Participants | 16 weeks |
|
|
|
| Secondary | Median Stereoacuity Score (Seconds of Arc) | Stereoacuity was tested at near in current refractive correction. Stereoacuity scores (measure as seconds of arc) were calculated based on the Randot Butterfly (scores: 2000, Nil) and Randot Preschool stereoacuity (scores: 800, 400, 200, 100, 60 and 40) test methods. Lower scores indicate better stereoacuity. Results of the Randot Butterfly test were analyzed as 2000 seconds of arc (if correct response). Nil was assigned a score of 4000 seconds of arc and was defined as (1) an incorrect response on the butterfly in absence of a correct response on the 800 seconds of arc level of the Randot Preschool stereoacuity test or (2) an incorrect response on the 800 seconds of arc level if the butterfly was not attempted. A logarithm base 10 transformation was used to convert stereoacuity scores (seconds of arc) to the log scale (conversion reference listed below), which was used to calculate descriptive statistics. Results of the descriptive analyses are reported as seconds of arc. | Participants who completed stereoacuity testing at the 16-week visit (regardless of whether or not the visit was completed within the pre-specified analysis window). Descriptive analyses were repeated for a subset of participants with no history of strabismus. | Posted | Median | Full Range | Seconds of arc | 16 weeks |
|
|
|
| Secondary | Distribution of Stereoacuity Scores (Participants With no History of Strabismus) | Stereoacuity was tested at near in current refractive correction. Stereoacuity scores (measure as seconds of arc) were calculated based on the Randot Butterfly (scores: 2000, Nil) and Randot Preschool stereoacuity (scores: 800, 400, 200, 100, 60 and 40) test methods. Lower scores indicate better stereoacuity. Results of the Randot Butterfly test were analyzed as 2000 seconds of arc (if correct response). Nil was assigned a score of 4000 seconds of arc and was defined as (1) an incorrect response on the butterfly in absence of a correct response on the 800 seconds of arc level of the Randot Preschool stereoacuity test or (2) an incorrect response on the 800 seconds of arc level if the butterfly was not attempted. | The analysis was limited to a subset of participants (no history of strabismus) who completed a 16-week exam regardless of whether or not the exam was completed within the pre-specified analysis window. | Posted | Count of Participants | Participants | 16 weeks |
|
|
|
| Secondary | Distribution of Change in Stereoacuity Scores From Baseline | Stereoacuity was tested at near in current refractive correction. Stereoacuity scores (seconds of arc) were calculated based on the Randot Butterfly (scores: 2000, Nil) and Randot Preschool stereoacuity (scores: 800, 400, 200, 100, 60 and 40) test methods. Lower scores indicate better stereoacuity. Results of the Randot Butterfly test were analyzed as 2000 (if correct response). Nil (4000 ) was defined as (1) an incorrect response on the butterfly in absence of a correct response on the 800 seconds of arc level of the Randot Preschool stereoacuity test or (2) an incorrect response on the 800 seconds of arc level if the butterfly was not attempted. For each visit, stereoacuity scores were ordered and assigned a rank score. Change in stereoacuity was calculated as the difference in ranked score between the enrollment and 16-week stereoacuity scores. | The analysis included all participants who completed stereoacuity testing at both baseline and the 16-week visit (regardless of whether or not the exam was completed within the pre-specified analysis window). | Posted | Count of Participants | Participants | Baseline and 16 weeks |
|
|
|
|
| Secondary | Distribution of Change in Stereoacuity Scores From Baseline (Participants With no History of Strabismus) | Stereoacuity was tested at near in current refractive correction. Stereoacuity scores (seconds of arc) were calculated based on the Randot Butterfly (scores: 2000, Nil) and Randot Preschool stereoacuity (scores: 800, 400, 200, 100, 60 and 40) test methods. Lower scores indicate better stereoacuity. Results of the Randot Butterfly test were analyzed as 2000 (if correct response). Nil (4000 ) was defined as (1) an incorrect response on the butterfly in absence of a correct response on the 800 seconds of arc level of the Randot Preschool stereoacuity test or (2) an incorrect response on the 800 seconds of arc level if the butterfly was not attempted. For each visit, stereoacuity scores were ordered and assigned a rank score. Change in stereoacuity was calculated as the difference in ranked score between the enrollment and 16-week stereoacuity scores. | The analysis included a subset of participants with no history of strabismus who completed stereoacuity testing at both baseline and the 16-week visit (regardless of whether or not the exam was completed within the pre-specified analysis window). | Posted | Count of Participants | Participants | Baseline and 16 weeks |
|
|
|
|
| Secondary | Binocular Treatment Group: Adherence and Fellow-eye Contrast (iPad Log File Data) | Participants assigned to binocular treatment were prescribed the binocular falling blocks game for 1 hour per day (allowing division into shorter sessions), 7 days per week for 16 weeks, with instructions to perform therapy a minimum of 4 days per week if unable to play for 7 days per week. The iPad device automatically recorded duration of game play, fellow-eye contrast, and performance. Adherence was calculated as the total hours of game play since baseline divided by the total prescribed hours (based on intended dose of 1 hour a day, 7 days per week) since baseline. The fellow-eye contrast was initially set to 20% (amblyopic eye always at 100%) and automatically increased or decreased by 10% increments (lowest level of 10%) or left unchanged from the last contrast level, based on the previous day's game play duration (at least 30 minutes required for contrast change) and performance (increased if scored 1000 points or more). Post hoc analysis: 4-week fellow-eye contrast. | The descriptive analysis included data from participants in the binocular treatment group who had log file data available. | Posted | Count of Participants | Participants | Entire study period, up to 16 weeks |
|
|
|
| Secondary | Binocular Treatment Group: Median Adherence With Prescribed Game Play (iPad Log File Data) | Participants assigned to binocular treatment were prescribed the binocular falling blocks game for 1 hour per day (allowing division into shorter sessions), 7 days per week for 16 weeks, with instructions to perform therapy a minimum of 4 days per week if unable to play for 7 days per week. The iPad device automatically recorded duration of game play, fellow-eye contrast, and performance. Adherence was calculated as the % of prescribed treatment actually completed: total hours of game play since baseline divided by the total prescribed hours (based on intended dose of 1 hour a day, 7 days per week) since baseline. | The descriptive analysis included data from participants in the binocular treatment group who had log file data available. | Posted | Median | Inter-Quartile Range | % of prescribed treatment completed | Entire study period, up to 16 weeks |
|
|
|
| Other Pre-specified | Percentage of Participants Reporting >75% of Prescribed Treatment Completed (Subjective Measures of Adherence) | Participants who were randomly assigned to binocular treatment were prescribed 1 hour of game play per day, 7 days a week while those assigned to the patching group were prescribed 2 hours of daily patching, 7 days per week. Parents were asked to record the amount of time that the participant played the binocular game (binocular treatment group) or wore the patch (patching group) each day on a calendar. At each study visit, the investigator estimated the frequency and duration of treatment that the participant completed based on the parent-reported calendars and discussion with the participant and/or parent(s). For analysis, the percentage of prescribed treatment completed was calculated as the total number of reported hours of treatment completed since baseline divided by the total number of prescribed hours (refer to the intended treatment dose/frequency listed above) since baseline. | The descriptive analysis included data from participants who completed the 16-week visit within the predefined analysis window (14 to <20 weeks after randomization). | Posted | Count of Participants | Participants | 16 Weeks from baseline |
|
|
|
| Other Pre-specified | Participants Who Received Non-protocol, Alternative Treatment During the Study | Participants who were randomly assigned to binocular treatment were prescribed 1 hour of game play per day, 7 days a week while those assigned to the patching group were prescribed 2 hours of daily patching, 7 days per week. The number of participants who received non-protocol, alternative treatment was tabulated by treatment group. | All randomized participants in the study. | Posted | Count of Participants | Participants | Entire study period, up to 16 weeks |
|
|
|
| Other Pre-specified | Safety Analysis: Distribution of the Change in Fellow-eye Visual Acuity From Baseline | Monocular distance visual acuity (VA) in current refractive correction (if required) in each eye by a certified examiner using the electronic ATS-HOTV visual acuity protocol for children <7 years and the E-ETDRS visual acuity protocol for children ≥ 7 years on a study-certified acuity tester displaying single surrounded optotypes. The change in visual acuity is analyzed as logMAR lines for the younger cohort and as letters for the older cohort. | Participants who completed the 16-week visit (regardless of whether or not the visit was completed within the pre-specified analysis window). | Posted | Count of Participants | Participants | 16-week visit |
|
|
|
| Other Pre-specified | Safety Analysis: Change in Fellow-eye Visual Acuity From Baseline (Younger Cohort) | Monocular distance visual acuity (VA) in current refractive correction (if required) in each eye by a certified examiner using the electronic Amblyopia Treatment Study single-surround HOTV (ATS-HOTV) visual acuity protocol for children <7 years and the Electronic Early Treatment Diabetic Retinoscopy Study (E-ETDRS) visual acuity protocol for children ≥ 7 years on a study-certified acuity tester displaying single surrounded optotypes. For the younger cohort, the level of visual acuity is analyzed in the log of the Minimum Angle of Resolution (logMAR) scale (approximate range: -0.2 to 1.7) such that higher scores indicate poorer VA. Change in VA is computed as logMAR lines (positive values indicate improvement), defined as the difference between the enrollment and 16-week acuities (logMAR) multiplied by 10. For this safety analysis, the change in fellow-eye visual acuity (logMAR lines) was computed by treatment group, adjusting for baseline visual acuity. | Participants who completed the 16-week visit (regardless of whether or not the visit was completed within the pre-specified analysis window). | Posted | Mean | 95% Confidence Interval | logMAR lines | 16-week visit |
|
|
|
|
| Other Pre-specified | Safety Analysis: Change in Fellow-eye Visual Acuity From Baseline (Older Cohort) | Monocular distance visual acuity (VA) in current refractive correction (if required) in each eye by a certified examiner using the Electronic Early Treatment Diabetic Retinoscopy Study (E-ETDRS) visual acuity protocol for children ≥ 7 years on a study-certified acuity tester displaying single surrounded optotypes. For the analyses in the older cohort, the level of VA is measured as letter scores (approximate range: 0 to 97 letters, lower scores indicate poorer VA) and change in VA from baseline is measured in letters (positive values indicate improvement), defined as the difference in letter scores between enrollment and follow-up. The change in fellow-eye visual acuity (letters) from baseline (positive values indicate improvement) was computed by treatment group, adjusting for baseline visual acuity. | Participants who completed the 16-week visit (regardless of whether or not the visit was completed within the pre-specified analysis window). | Posted | Mean | 95% Confidence Interval | Letters | 16-week visit |
|
|
|
|
| Other Pre-specified | Safety Analysis: Development of a New Tropia and/or Worsening of a Pre-existing Deviation by 10 pd | Ocular alignment will be assessed in current refractive correction by the cover/uncover test, simultaneous prism and cover test (SPCT), and prism and alternate cover test (PACT) in primary gaze at distance (3 meters) and at near (1/3 meter). Participants were classified according to whether they met the any of the following criteria at the 16-week visit: development of a new tropia (measured by SPCT) and/or worsening of a pre-existing deviation by 10 prism diopters (pd) measured by SPCT. | Participants who completed the 16-week visit (regardless of whether or not the visit was completed within the pre-specified analysis window). | Posted | Count of Participants | Participants | 16 weeks |
|
|
|
|
| Other Pre-specified | Safety Analysis: Distribution of Diplopia Frequency at 16 Weeks (Parent-reported) | A standardized questionnaire was administered to participants and their parents to assess the presence and frequency of any diplopia since the last study visit. | Participants whose parent completed a 16-week diplopia assessment. | Posted | Count of Participants | Participants | 16 weeks |
|
|
|
|
| Other Pre-specified | Safety Analysis: Distribution of Diplopia Frequency at 16 Weeks (Participant-reported) | A standardized questionnaire was administered to participants and their parents to assess the presence and frequency of any diplopia since the last study visit. | Participants who completed a 16-week diplopia assessment. | Posted | Count of Participants | Participants | 16 weeks |
|
|
|
|
| Other Pre-specified | Safety Analysis: Distribution of Maximum Frequency of Diplopia Reported Across Follow-up (Parent-reported) | A standardized questionnaire was administered to participants and their parents to assess the presence and frequency of any diplopia since the last study visit. | Participants whose parent completed a diplopia assessment at any follow-up visit (4-week, 8-week, 12-week, 16-week) | Posted | Count of Participants | Participants | Across study follow-up visits, up to 16 weeks |
|
|
|
| Other Pre-specified | Safety Analysis: Distribution of Maximum Frequency of Diplopia Reported Across Study Follow-up (Participant-reported) | A standardized questionnaire was administered to participants and their parents to assess the presence and frequency of any diplopia since the last study visit. | Participants who completed a diplopia assessment at any follow-up visit (4-week, 8-week, 12-week, 16-week) during the study. | Posted | Count of Participants | Participants | Across study follow-up visits, up to 16 weeks |
|
|
|
| 0 |
| 190 |
| 0 |
| 190 |
| EG001 | Patching Treatment Younger | Patching 2 hours per day, 7 days per week Patching 2 hours per day, 7 days per week | 0 | 195 | 0 | 195 |
| EG002 | Binocular Treatment Older | Binocular computer game play 1 hour per day, 7 days per week (minimum of 4 days per week) iPad®: Binocular therapy on iPad® | 0 | 40 | 0 | 40 |
| EG003 | Patching Treatment Older | Patching 2 hours per day, 7 days per week Patching 2 hours per day, 7 days per week | 0 | 60 | 0 | 60 |
Not provided
Not provided
| D012678 | Sensation Disorders |
| D009461 | Neurologic Manifestations |
| D005128 | Eye Diseases |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| Between 18 and 65 years |
|
| >=65 years |
|
|
|
|
| Male |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Superiority |
| A modified intent-to-treat analysis was performed using an ANCOVA model to compare the change in amblyopic-eye visual acuity from baseline to 16 weeks for two treatments (2-sided hypothesis test), adjusting for baseline visual acuity. For this sensitivity analyses, the primary analysis was repeated but excluded data from participants who completed the 16-week visit outside of the pre-specified 16 +/- 1 week protocol window (n=10 participants). | Mean Difference (Final Values) | -2.7 | 2-Sided | 95 | -5.9 | 0.5 | A 2-sided 95% confidence interval was computed on the adjusted treatment group difference (binocular treatment - patching) evaluating change in amblyopic-eye visual acuity from baseline to the 16-week visit. | Superiority |
| A modified intent-to-treat analysis was performed using an ANCOVA model to compare the change in amblyopic-eye visual acuity from baseline to 16 weeks (14 to <20 week window) for two treatments (2-sided hypothesis test), adjusting for baseline visual acuity. For this sensitivity analyses, the primary analysis was repeated but excluded data from participants later found to be ineligible for the study (n=2). | Mean Difference (Final Values) | -2.8 | 2-Sided | 95 | -5.9 | 0.3 | A 2-sided 95% confidence interval was computed on the adjusted treatment group difference (binocular treatment - patching) evaluating change in amblyopic-eye visual acuity from baseline to the 16-week visit. | Superiority |
| The primary analysis was repeated for the treatment group comparison of change in amblyopic-eye from baseline to 16 weeks, adjusting for baseline visual acuity. For this sensitivity analysis, multiple imputation was used to impute 16-week visual acuity scores for participants who missed the exam (n=3) or completed the 16-week exam outside of the pre-specified analysis window (n=2). | Mean Difference (Final Values) | -1.9 | 2-Sided | 95 | -5.0 | 1.2 | A 2-sided 95% confidence interval was computed on the adjusted treatment group difference (binocular treatment - patching) evaluating change in amblyopic-eye visual acuity from baseline to the 16-week visit. | Superiority |
| An ANCOVA model was fit to compare the change in amblyopic-eye visual acuity from baseline to 16 weeks (14 to <20 week window) for two treatments (2-sided hypothesis test), adjusting for baseline visual acuity. For this post hoc sensitivity analyses, the primary analysis was repeated but included data from participants who completed the 16-week visit outside the analysis window (n=2, range:14 to 28 weeks post randomization). | Mean Difference (Final Values) | -2.5 | 2-Sided | 95 | -5.5 | 0.5 | A 2-sided 95% confidence interval was computed on the adjusted treatment group difference (binocular treatment - patching) evaluating change in amblyopic-eye visual acuity from baseline to the 16-week visit. | Superiority |
| An ANCOVA model was fit to compare the change in amblyopic-eye visual acuity from baseline to 16 weeks (14 to <20 week window) for two treatments (2-sided hypothesis test), adjusting for baseline visual acuity. For this sensitivity analyses, the primary analysis was repeated but included prior amblyopia treatment as an adjustment covariate (in addition to baseline visual acuity) in the model. | Mean Difference (Final Values) | -2.6 | 2-Sided | 95 | -5.7 | 0.4 | A 2-sided 95% confidence interval was computed on the adjusted treatment group difference (binocular treatment - patching) evaluating change in amblyopic-eye visual acuity from baseline to the 16-week visit. | Superiority |
| 2 LogMAR lines (10-14 letters) better |
|
| 1 LogMAR line (5-9 letters) better |
|
| 0 LogMAR line (within 4 letters) |
|
| 1 LogMAR line (5-9 letters) worse |
|
| 2 LogMAR lines (10-14 letters) worse |
|
| ≥3 LogMAR lines (≥ 15 letters) worse |
|
| 20/160 (38-42 letters) |
|
| 20/125 (43-47 letters) |
|
| 20/100 (48-52 letters) |
|
| 20/80 (53-57 letters) |
|
| 20/63 (58-62 letters) |
|
| 20/50 (63-67 letters) |
|
| 20/40 (68-72 letters) |
|
| 20/32 (73-77 letters) |
|
| 20/25 (78-82 letters) |
|
| 20/20 (83-87 letters) |
|
| 20/16 (88-92 letters) |
|
| Binomial regression was used for the treatment group comparison of the proportion of participants classified as improving 2 or more logMAR lines (10 or more letters if E-ETDRS) from baseline at the 16-week visit, adjusting for baseline visual acuity. | Risk Difference (RD) | -15 | 2-Sided | 95 | -31 | 2 | Binomial regression was used to compare the group proportions (binocular treatment - patching) of participants classified as improving 2 or more logMAR lines (≥ 10 letters) from baseline at the 16-week visit. | Superiority |
| 8-week visit |
|
|
| 12-week visit |
|
|
| 16-week visit |
|
|
| Superiority |
| Male |
|
|
| White/Non-Hispanic |
|
|
| Non-White or Hispanic |
|
|
| Age at baseline: 5 to <7 years |
|
|
| Age at baseline: 7 to <13 years |
|
|
| Baseline amblyopic-eye VA: 20/80 to 20/200 |
|
|
| Baseline amblyopic-eye VA: 20/63 |
|
|
| Baseline amblyopic-eye VA: 20/50 |
|
|
| Baseline amblyopic-eye VA: 20/40 |
|
|
| Baseline stereoacuity: Nil |
|
|
| Baseline stereoacuity: Better than Nil |
|
|
| No presence of a near heterotropia at baseline |
|
|
| Presence of a near heterotropia at baseline |
|
|
| No prior amblyopia treatment |
|
|
| Prior amblyopia treatment |
|
|
| Baseline: Age 5 to <7 yrs, no prior treatment |
|
|
| Baseline: Age 5 to <7 yrs, prior treatment |
|
|
| Baseline: Age 7 to <13 yrs, no prior treatment |
|
|
| Baseline: Age 7 to <13 yrs, prior treatment |
|
|
| Exploratory subgroup analyses were conducted to assess the treatment effect according to subgroups of baseline factors. An analysis of covariance was used to test the interaction between treatment group and race/ethnicity status (White/non-Hispanic, Non-White or Hispanic), adjusting for the main effects of the interaction term and baseline covariates of age and visual acuity. | ANCOVA | Four participants (1 binocular treatment group, 3 patching group) were excluded from the analysis due to unknown/not reported race/ethnicity status. | 0.54 | The a priori threshold for statistical significance of the interaction term (race/ethnicity status and treatment group) was 0.05. | Superiority |
| Exploratory subgroup analyses were conducted to assess the treatment effect according to subgroups of baseline factors. An analysis of covariance was used to test the interaction between treatment group and age at baseline (treated as a continuous factor in the model), adjusting for the main effects of the interaction term and baseline visual acuity. | ANCOVA | 0.80 | The a priori threshold for statistical significance of the interaction term (age and treatment group) was 0.05. | Superiority |
| Exploratory subgroup analyses were conducted to assess the treatment effect according to subgroups of baseline factors. An analysis of covariance was used to test the interaction between treatment group and baseline amblyopic-eye visual acuity (treated as a continuous factor in the model), adjusting for the main effects of the interaction term and baseline age. | ANCOVA | 0.99 | The a priori threshold for statistical significance of the interaction term (baseline amblyopic-eye visual acuity and treatment group) was 0.05. | Superiority |
| Exploratory subgroup analyses were conducted to assess the treatment effect according to subgroups of baseline factors. An analysis of covariance was used to test the interaction between treatment group and prior amblyopia treatment (Yes/No), adjusting for the main effects of the interaction term and baseline covariates of age and visual acuity. | ANCOVA | 0.87 | The a priori threshold for statistical significance of the interaction term (prior amblyopia treatment and treatment group) was 0.05 | Superiority |
| Exploratory subgroup analyses were conducted to assess the treatment effect according to subgroups of baseline factors. An analysis of covariance was used to test the interaction between treatment group and baseline stereoacuity (nil, better than nil), adjusting for the main effects of the interaction term and baseline covariates of age and visual acuity. | ANCOVA | 0.33 | The a priori threshold for statistical significance of the interaction term (baseline stereoacuity and treatment group) was 0.05. | Superiority |
| Exploratory subgroup analyses were conducted to assess the treatment effect according to subgroups of baseline factors. An analysis of covariance was used to test the interaction between treatment group and presence of a near heterotropia (measured by SPCT) at baseline (Yes/No), adjusting for the main effects of the interaction term and baseline covariates of age and visual acuity. | ANCOVA | 0.23 | The a priori threshold for statistical significance of the interaction term (presence of a near heterotropia at baseline and treatment group) was 0.05. | Superiority |
| White/Non-Hispanic |
|
| Non-White or Hispanic |
|
| Baseline amblyopic-eye VA: 20/80 to 20/200 |
|
| Baseline amblyopic-eye VA: 20/63 |
|
| Baseline amblyopic-eye VA: 20/50 |
|
| Baseline amblyopic-eye VA: 20/40 |
|
| No prior amblyopia treatment |
|
| Prior amblyopia treatment |
|
| Baseline stereoacuity: Nil |
|
| Baseline stereoacuity: Better than Nil |
|
| No presence of a near heterotropia at baseline |
|
| Presence of a near heterotropia at baseline |
|
| 4000 seconds of arc |
|
| 2000 seconds of arc |
|
| 800 seconds of arc |
|
| 400 seconds of arc |
|
| 200 seconds of arc |
|
| 100 seconds of arc |
|
| 60 seconds of arc |
|
| 40 seconds of arc |
|
|
| Participants with no history of strabismus |
|
|
| 4000 seconds of arc |
|
| 2000 seconds of arc |
|
| 800 seconds of arc |
|
| 400 seconds of arc |
|
| 200 seconds of arc |
|
| 100 seconds of arc |
|
| 60 seconds of arc |
|
| 40 seconds of arc |
|
| Within 1 level |
|
| 2 or more levels better |
|
The Wilcoxon rank-sum test was used to compare the distribution of change in stereoacuity levels from baseline to 16 weeks by treatment group.
| Wilcoxon (Mann-Whitney) |
| 0.83 |
A priori threshold for statistical significance was 0.05 |
| Superiority |
| Within 1 level |
|
| 2 or more levels better |
|
The Wilcoxon rank-sum test was used to compare the distribution of change in stereoacuity levels from baseline to 16 weeks by treatment group.
| Wilcoxon (Mann-Whitney) |
| 0.69 |
A priori threshold for statistical significance was 0.05. |
| Superiority |
| Fellow-eye contrast of 100% (16 weeks) |
|
|
| Fellow-eye contrast of 20% or worse (16 weeks) |
|
|
| Fellow-eye contrast of 100% (4 weeks) |
|
|
| 1 line (5-9 letters) better |
|
| 0 line (within 4 letters) |
|
| 1 line (5-9 letters) worse |
|
| 2 lines (10-14 letters) worse |
|
Fisher's exact test was used to perform the treatment group comparison of the proportion of participants who developed a new ocular deviation and/or worsening of a pre-existing ocular deviation by 10 prism diopters at the 16-week visit.
| Fisher Exact |
| 0.68 |
| Superiority |
| Diplopia: Less than once a week |
|
| Diplopia: Once a week |
|
| Diplopia: Once a day |
|
| Diplopia: Up to 10 times a day |
|
| Diplopia: >10 times a day |
|
| All the time |
|
| Cochran-Armitage trend test |
| 0.48 |
| Superiority |
| The Fisher exact test was used to compare the percentage of parents who reported that their child had experienced diplopia (yes/no) at the 16-week visit by treatment group. | Fisher Exact | >0.99 | Superiority |
| The frequency of diplopia, across categories of diplopia, was compared between the treatment groups using the Cochran-Armitage trend test. | Cochran-Armitage trend test | >0.99 | Superiority |
| Diplopia: Less than once a week |
|
| Diplopia: Once a week |
|
| Diplopia: Once a day |
|
| Diplopia: Up to 10 times a day |
|
| Diplopia: >10 times a day |
|
| All the time |
|
| Cochran-Armitage trend test |
| 0.02 |
| Superiority |
| The Fisher exact test was used to compare the percentage of participants who reported diplopia (yes/no) at the 16-week visit by treatment group. | Fisher Exact | >0.99 | Superiority |
| The frequency of diplopia, across categories of diplopia, was compared between the treatment groups using the Cochran-Armitage trend test. | Cochran-Armitage trend test | >0.99 | Superiority |
| Diplopia: Less than once a week |
|
| Diplopia: Once a week |
|
| Diplopia: Once a day |
|
| Diplopia: Up to 10 times a day |
|
| Diplopia: >10 times a day |
|
| All the time |
|
| Diplopia: Less than once a week |
|
| Diplopia: Once a week |
|
| Diplopia: Once a day |
|
| Diplopia: Up to 10 times a day |
|
| Diplopia: >10 times a day |
|
| All the time |
|